← FDA Drug Approvals (Drugs@FDA)
ENBUMYST
NDA · New Drug Application · Sponsor: CORSTASIS THERAP · Approved 2025-09-12
Drug application
- FDA Application #
NDA219500- Application type
- New Drug Application
- Brand name
- ENBUMYST
- Generic name
- BUMETANIDE
- Active ingredients
- BUMETANIDE
- Dosage form
- SPRAY
- Route
- NASAL
- Marketing status
- Prescription
- Sponsor
- CORSTASIS THERAP
- Manufacturer
- Corstasis USA LLC
- First approval
- 2025-09-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown